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ABSTRACT 
Liver ischemia and reperfusion injury (IRI) remains a serious clinical problem affecting liver 
transplantation outcomes. IRI causes up to 10% of early organ failure and predisposes to 
chronic rejection. Cyclooxygenase-2 (COX-2) is involved in different liver diseases but the 
significance of COX-2 in IRI is a matter of controversy. This study was designed to elucidate 
the role of COX-2 induction in hepatocytes against liver IRI. In the present work, hepatocyte-
specific COX-2 transgenic mice (hCOX-2-Tg) and their wild-type (Wt) littermates were 
subjected to IRI. hCOX-2-Tg mice exhibited lower grades of necrosis and inflammation than 
Wt mice, in part by reduced hepatic recruitment and infiltration of neutrophils, with a 
concomitant decrease in serum levels of pro-inflammatory cytokines. Moreover, hCOX-2-Tg 
mice showed a significant attenuation of the IRI-induced increase in oxidative stress and 
hepatic apoptosis, an increase in autophagic flux and a decrease in endoplasmic reticulum 
stress than in Wt mice. Interestingly, ischemic pre-conditioning of Wt mice resembles the 
beneficial effects observed in hCOX-2-Tg mice against IRI due to preconditioning-derived 
increase in endogenous COX-2, which is mainly localized in hepatocytes. Furthermore, 
measurement of PGE2 levels in plasma from patients who underwent liver transplantation 
revealed a significantly positive correlation of PGE2 levels and graft function, and an inverse 
correlation with the time of ischemia. Conclusion: These data support the view of a novel 
protective effect of hepatic COX-2 induction and the consequent rise of derived 
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Liver ischemia and reperfusion injury (IRI) remains a serious clinical problem affecting liver 
transplantation outcomes. IRI causes up to 10% of early organ failure and predisposes to 
chronic rejection (1). Moreover, the shortage of donor organs has led to an increased use of 
marginal livers, which are more susceptible to IRI (2). The mechanisms underlying hepatic 
ischemia and reperfusion injury are complex. However it is now becoming clear that reactive 
oxygen species (ROS) activate redox-regulated transcription factors such as nuclear factor-κB 
(NF-κB), which trigger the secretion of pro-inflammatory cytokines, lead to tissue injury 
(3,4). In response to these cytokines, neutrophils are recruited into the injured tissue and they 
further release ROS, cytokines, myeloperoxidase (MPO) and other mediators which 
aggravate tissue damage (5,6). Moreover, oxidative stress induces the translocation of the 
nuclear factor-erythroid 2-related factor (NRF2), and the expression of several antioxidant 
and detoxification enzymes, such as glutathione-S-transferases, quinine oxidoreductase 1, 
glutamate cysteine ligase and heme oxygenase 1, which in turn decrease ROS and reduce 
oxidative stress (7). 
 
Additionally, IRI impairs autophagy (8) and activates endoplasmic reticulum stress (ERS) 
(6,9). Autophagy is a catabolic process mainly regulated by the conjugation of microtubule 
associated protein 1 light chain 3 (LC3-I) to the membrane lipid phosphatidylethanolamine to 
form LC3-II. LC3-II serves as a recognition site for LC3-binding chaperones such as p62 that 
deliver their cargo to autophagosomes (10). Then, autophagosomes reach lysosomes and fuse 
to form autophagolysosomes, allowing the degradation by lysosomal acid hydrolases of their 
contents (11). ERS, initiated by a defensive process known as the unfolded protein response 
(UPR), comprises cellular mechanisms for adaptation of cell survival characterized by 
translational arrest of protein synthesis. UPR is mediated by the release of intraluminal 
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initiation factor 2 kinase (PERK), activating transcription factor 6 (ATF-6), and the inositol 
requiring 1α (IRE1α). If the cell fails to adapt, oxidative and inflammatory signaling 
pathways are activated leading to apoptosis through PERK-mediated C/EBP homologous 
protein (CHOP) expression and signal-regulated kinase 1/C-jun N-terminal kinase (JNK), 
among others (12). 
 
In the liver, and in various tissues, short periods of ischemia protect efficiently against 
subsequent IRI. This phenomenon, known as ischemic preconditioning (IPC), indicates that a 
brief ischemic insult triggers a protective biological reaction in the liver which is associated 
with inhibition of pro-apoptotic pathways (13). 
 
Cyclooxygenase (COX)-1 and -2 catalyze the first step in prostanoid biosynthesis. COX-1 is 
constitutively expressed in many tissues, whereas COX-2 is induced by a variety of stimuli 
(14) and its expression has been detected in several liver pathologies (15). In the other hand, 
hepatocyte-specific constitutive expression of COX-2 exerts an efficient protection against 
acute liver injury by an antiapoptotic/antinecrotic effect (16). Controversial results have been 
published related to COX-2 and IRI. It was reported that several COX-2 inhibitors protect 
mice and rats from hepatic IRI (17–19). However, Kuzumoto et al. (20) reported that the 
prostaglandin E2 (PGE2)-EP4 signaling pathway has an inhibitory role in hepatic IRI, showing 
that EP4 agonists effectively protect against IRI. Since there is a lack of studies on the effects 
of hepatic COX-2 induction and prostaglandins during liver IRI, in the present study we have 
demonstrated that constitutive hepatocyte expression of COX-2 significantly protects against 
IRI by decreasing inflammation, oxidative stress, apoptosis, and ERS. Moreover, the 
constitutive hepatocyte expression of COX-2 increase survival and autophagic signaling 
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EXPERIMENTAL PROCEDURES  
Patients 
Arterial PGE2 plasma concentration in a cohort of 63 human liver transplants from cadaveric 
donors, 60 min after reperfusion, was analyzed. This analysis was approved by the Ethics 
Committee on Clinical Research of the University General Hospital Gregorio Marañón 
(Madrid, Spain, June 2016). All the patients had already signed a previous informed consent 
allowing the plasma analysis. Early graft function was assessed by the Toronto classification 
that accounts for elevation of ALT, coagulopathy and bile flow (21). Patients were classified 
as good early graft function (grades I and II) and bad early graft dysfunction (grades III and 
IV). Graft ischemia time was recorded in all cases. 
 
Animal experimentation  
Male twelve-weeks-old COX-2 transgenic mice (hCOX-2-Tg) and their wild-type (Wt) 
siblings were used. The mice were divided randomly into four groups: 1) Sham operation 
(Sh) group; 2) hepatic ischemia-reperfusion (I/R) group; 3) ischemic preconditioning (Wt 
PC) group; and 4) 5,5-dimethyl-3(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5H)-
furanone (DFU) treated group (Wt PC DFU and hCOX-2-Tg DFU). Animals were 
anesthetized with isoflurane 1.2-2% and a model of segmental (70%) warm hepatic ischemia-
reperfusion protocol was assessed (22). Reperfusion was initiated by removal of the clamp 
for 4 h and 24 h. For IPC experiments, Wt mice were subjected to 20 min of ischemia 
followed by 30 min of reperfusion prior to 90 min of ischemia and 4 h of reperfusion. For 
DFU treatment, Wt PC and hCOX-2-Tg mice were injected intraperitoneally with 5 mg/kg 
DFU in DMSO three days and 45 min before the PC or hepatic ischemia, respectively. 
Control mice were treated with DMSO. The animals were sacrificed and livers were removed 
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containing 30% sucrose in PBS or fixed in 10% buffered formalin. Plasma was obtained from 
the inferior cava vein. All animal experimentation was controlled following the 
recommendations of the Federation of European Laboratory Animal Science Associations 
(FELASA) on health monitoring, European Community Law (2010/63/UE) and the Spanish 
law (R.D. 53/2013) with approval of the Ethics Committee of the Spanish National Research 
Council, Spain.  
 
Whole transcriptome analysis 
Total RNA was obtained using the mirVana™ miRNA Isolation Kit (Thermo Fisher 
Scientific, Waltham, MA USA), prepared for sequencing using the Illumina TruSeq RNA 
Sample Prep Kit v2 according to the manufacturer’s instructions, and sequenced on a Hiseq 
4000 platform (Macrogen, Geumchcon-gu, Seoul, Korea). The Illumina Hiseq 4000 
generated raw images utilizing HCS (HiSeq Control Software v3.3) for system control and 
base calling through an integrated primary analysis software called RTA (Real Time 
Analysis. v2.7.3). The BCL (base calls) binary was converted into FASTQ utilizing illumina 
package bcl2fastq (v2.17.1.14). Trimmed 100-bp sequenced paired-end reads were mapped to 
reference genome with HISAT2. After the read mapping, Stringtie was used for transcript 
assembly. Expression profile was calculated for each sample and transcript/gene as FPKM 
(Fragment per Kilobase of transcript per Million mapped reads). 
 
Data analysis. 
Data are expressed as means ± S.E. Statistical significance was tested by one-way ANOVA, 
followed by Bonferroni’s test. Analysis was performed by using the statistical software 
GraphPad Prism 5. For patients, the Kolmogorov-Smirnov test was used to assess the 
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samples, Mann-Whitney rank-sum test were used. To assess a significant relationship 
between two variables, Spearman’s correlation was calculated. Data were analyzed using 
SPSS IBM for Windows statistical package, version 24 (SPSS Inc, Chicago, IL, USA). For 
all statistical tests, a P value <0.05 was considered significant. 
 
RESULTS 
Hepatic COX-2 expression protects transgenic mice from IRI-induced liver damage. 
We used our previously described transgenic mice model, hCOX-2-Tg, that constitutively 
expresses human COX-2 in hepatocytes under the control of the human APOE promoter 
containing the hepatic control region (HCR) (23). The expression of hCOX-2 in these livers 
is comparable to the endogenous levels reached in regenerating liver after partial 
hepatectomy (24). No changes in COX-2 mRNA or protein levels were found in hCOX-2-Tg 
mice after 90 min of ischemia and 4 h or 24 h of reperfusion (Supplementary Fig. 1B and Fig. 
1A). Furthermore, Cox-1 mRNA and COX-1 protein levels were maintained without changes 
in all conditions (Supplementary Fig. 1A and Fig. 1A). 
PGE2 levels were, as expected, significantly higher in hCOX-2-Tg when compared to Wt 
mice, even when there is a clear tendency to increase PGE2 hepatic levels in Wt mice 24 h 
post IRI (Fig. 1B). This increase is associated to an induction of endogenous COX-2 
expression (Fig. 6E). Liver sections were stained with hematoxylin/eosin and then evaluated 
by an experienced liver pathologist. Extensive parenchymal areas of necrosis and vascular 
congestion were observed in Wt mice at 4 h and 24 h after IRI. Necrotic hepatocytes were 
characterized by condensation of chromatin, swelling of organelles, karyolysis and cell 
rupture. These pathological features were significantly attenuated in hCOX-2-Tg hepatocytes 
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Elevated serum levels of aminotransferases such as alanine transaminase (ALT) and aspartate 
aminotransferase (AST) reflect the degree of hepatic cell damage. As shown in Fig. 1D, IRI 
resulted in a marked elevation of serum ALT and AST levels, but they were significantly 
lower in hCOX-2-Tg mice after 4 h of reperfusion. Lactate dehydrogenase (LDH) activity 
was measured as necrotic marker (25). The increase in LDH activity after IRI was much 
lower in hCOX-2-Tg mice at 4 h and 24 h (Fig. 1D), confirmed by the quantification of the 
necrosis grade (Fig. 1E).  
 
Alteration of gene expression profile after ischemia/reperfusion injury.  
Murine whole transcriptome sequencing was performed in order to examine the different 
gene expression profiles in the hCOX-2 Tg mice after IRI (90 min ischemia, 4 h reperfusion). 
A total of 70 genes showed significant differential expression (false discovery rate ≤ 0.05, 
log2 ≥2; Fig. 2A). Among these genes, 18 genes were up-regulated and 52 genes were down-
regulated (Fig. 2B). To elucidate the roles of differentially expressed genes, GO (gene 
ontology) analysis was used to analyze the biological functions of those genes (Fig. 2C and 
Supplementary Table 4). The results indicated that several pathways were consistently 
modified after IRI between mice models, such as biological processes related with the 
response to stress and inflammation. Taking into account that inflammation and oxidant 
stress are the disease mechanisms most commonly implicated in hepatic IRI (5,6), we 
decided to validate and to study in depth these two pathways. 
 
COX-2 expression reduced hepatic inflammation in the I/R injury model. 
Pro-inflammatory cytokines such as tumor necrosis factor  (TNF-α) and interleukin 1 (IL-
1β) are released by activated Kupffer cells, and induce hepatocellular and endothelial injuries. 
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activated in IRI, by ROS production (26). Constitutive COX-2 expression reduced the hepatic 
mRNAs levels of these pro-inflammatory cytokines including Nlrp3 inflammasome. 
However, interleukin 10 (Il-10) expression, an anti-inflammatory interleukin, was increased 
in hCOX-2-Tg mice. (Fig. 3A). Consistently, plasmatic levels of IL-1β, interleukin 6 (IL-6) 
and TNF-α reached up the higher levels at 24 h of reperfusion, while they were significantly 
lower in hCOX-2-Tg vs. Wt (Fig. 3B). Our previous data showed lower levels of 
inflammatory markers and reduced hepatic leukocyte recruitment and infiltration in hCOX-2-
Tg mice upon different liver injuries (16,27). There was no evidence of neutrophil 
accumulation after 4 h of reperfusion. Tissue MPO activity, an index of neutrophil 
infiltration, was found increased at 24 h of reperfusion in Wt mice (Fig. 3C). Additionally, at 
this time point, immunohistochemistry analysis showed lesser levels of infiltrating Ly6G
+
 
cells (a neutrophil plasma membrane biomarker) when comparing hCOX-2-Tg vs. Wt IR 
groups (Fig. 3D). 
NF-κB is not only an important mediator of the inflammatory response but its signaling 
pathway is a key component in the progression of IR derived injury (28). To know whether 
NF-κB is involved in the regulation of inflammation in our model, nuclear p65 and 
phosphorylated cytosolic IκBα protein levels were analyzed by Western blot in Wt and 
hCOX-2-Tg liver subjected to IRI. We found in Wt IRI mice an important increase in nuclear 
p65 localization and in pIκBα protein levels in hepatocytes, suggesting a strong NF-κB 
pathway activation, whereas this effect resulted attenuated in hCOX-2-Tg mice (Fig. 3E-F). 
 
Constitutive hepatocyte COX-2 expression leads to decreased apoptosis and to an increase 
in antioxidant response. 
The apoptotic process is a consequence of reperfusion, which marks the onset and 
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hepatic COX-2 expression (23,30); to further explore the protective effect of COX-2, 
caspase-3 activity and some key apoptotic/anti-apoptotic protein levels were measured. As 
shown in supplementary Fig. 2A, caspase-3 activity increased only in Wt mice after IRI. 
Moreover, an important increase in the BCL-2-associated X protein/ B-cell lymphoma 2 
(BAX/BCL-2) ratio was found in Wt IRI mice at 24 h of reperfusion. This effect was 
attenuated in hCOX-2-Tg IRI mice (Supplementary Fig. 2B). Additionally, after IRI an 
increase in p-AKT/AKT and in p-AMPKα/AMPKα ratios were observed in hCOX-2-Tg 
when compared to Wt mice (Supplementary Fig. 2C). DFU treatment reversed the increase in 
p-AKT/AKT and in p-AMPKα/AMPKα ratios (data not shown). 
 
IRI is associated with the generation of ROS and other oxidative stress-related molecules. In 
this regard, some COX-2-derived prostanoid actions were associated to an enhanced 
antioxidant response (31). The expression of several antioxidant genes is shown in Fig. 4A. 
The mRNA levels of Nfr2, heme oxygenase 1 (Hmox1), glutathione peroxidase (Gpx), 
glutathione reductase (Gsr), cytosolic superoxide dismutase Sod1 and mitochondrial Sod2, 
were increased in hCOX-2-Tg mice after 4 h of IRI vs. Wt IRI. To gain insight into the 
mechanisms involved, nuclear extracts were prepared to quantify the protein levels of NRF2. 
Nuclear localization of NRF2 increased in hCOX-2-Tg after IRI (Fig. 4B), and mainly 
hepatocyte location was corroborated by immunofluorescence staining (Fig. 4C). In this 
sense, we use albumin as a specific hepatocyte marker, and CLEC4F as Kupffer cell marker 
(32). Moreover, the activities of antioxidants enzymes were measured and there was an 
increase in MnSOD, GSR and GPX activities at 4 h in hCOX-2-Tg mice after IRI (Fig. 4D 
and Supplementary Table 1). Indeed, MnSOD protein levels were already increased in 
hepatocytes from hCOX-2-Tg in sham conditions. This difference was maintained at 4 h or 
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Dihydroethidium (DHE) staining was performed as an indirect measurement of ROS 
production. ROS levels were significantly increased in Wt IRI condition at 4 h (Fig. 4E and 
Supplementary Fig. 3C). These results were confirmed by the measurement of lipid 
peroxidation (LPO) levels. LPO increased by IRI only in livers of Wt mice (Supplementary 
Fig. 3D) suggesting a diminished ROS production in hCOX-2-Tg mice. In line with this, total 
glutathione content was decreased after IRI, but to a lesser extent in hCOX-2-Tg. Also, the 
ratio of oxidized/total glutathione (GSSG/GSHt), evaluated as an intracellular redox status 
marker, was significantly higher in Wt IRI mice after 4 h (Fig. 4F). Overall, these data are 
compatible with an attenuated oxidative stress in hCOX-2-Tg IRI mice when compared to Wt 
IRI. 
 
Hepatocyte COX-2 expression attenuates endoplasmic reticulum stress and activates 
autophagy after IRI. 
It has been suggested that impaired autophagy increased hepatocellular damage during the 
reperfusion period. Therefore, we analyzed p62 and LC3-II protein levels. As shown in Fig. 
5A-C, p62 protein levels were decreased in hCOX-2-Tg after IRI whereas LC3-II and 
autophagy-related gene 7 (ATG7) levels increased. Overall, these data suggest an 
improvement of the autophagic process in hCOX-2-Tg liver after IRI. This effect was also 
observed using electron microscopy since we detected more double membrane structures 
(autophagosomes) in hCOX-2-Tg than in Wt after IRI (Fig. 5D). 
 
Next, we examined if the changes in the autophagic process found during IRI were 
accompanied by activation of the ERS signaling pathway. Significant increases of GRP78 (at 
24 h), CHOP (at 4 h and 24 h) and p-JNK (at 4 h) were found in Wt mice after IRI vs. the 
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attenuated activation of the ERS signaling in these mice livers. Moreover, DFU treatment, 
increased JNK phosphorylation in hCOX-2-Tg mice (data not shown). 
 
Ischemic preconditioning attenuated I/R damage in Wt mice and was associated to 
endogenous COX-2 induction. 
To check the possible role of endogenous COX-2 induction in the protective effect observed 
after IRI, we performed IPC in the Wt mice and inhibition of COX-2 activity in Wt IPC and 
hCOX-2-Tg mice with the COX-2 specific inhibitor DFU. When compared to Wt IRI, Wt 
IPC exhibited a decrease in the necrosis grade and vascular congestion, whereas DFU 
treatment led to a significantly higher necrosis grade in Wt IPC and hCOX-2-Tg IRI mice 
(Fig. 6A-B). These effects were reflected in the plasma levels of ALT and AST and LDH in 
accordance with the necrosis grade (Fig. 6C). Consistently, increased levels of PGE2 were 
observed in the Wt IPC group and in hCOX-2-Tg mice when compared to Wt IRI animals, 
while DFU decreased these levels in both conditions (Fig. 6D). Higher PGE2 levels were 
associated with more pronounced changes in mRNA and protein levels of endogenous COX-
2 in Wt IPC vs Wt mice after IRI (Fig. 6E). Moreover, we confirmed that endogenous COX-2 
induced-expression is mainly in the hepatocytes (Fig. 6F). These data confirm the specificity 
of COX-2-dependent PGE2 involvement in the protective effect.  
To assess the contribution of endogenous COX-2 to the protection against IRI, the expression 
profile of inflammatory and antioxidants genes was analyzed and, as shown in Fig. 7A, IPC 
decreased Il-1b, Il-6, Tnfa and Nlrp3 expression and increased Il-10 in Wt IPC when 
compared to Wt IRI, resembling the constitutive COX-2 expression phenotype. The 
expression of antioxidants genes was increased in Wt mice subjected to IPC surgery; 
however, DFU treatment had no effect over these genes probably because the decrease in 
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Elevated plasmatic PGE2 levels correlates with an improvement of liver function after LT.  
To evaluate the contribution of PGE2 dynamics in a clinical setting, we analyzed arterial 
plasma PGE2 concentration in a cohort of 63 patients after receiving a liver transplant (LT). 
Arterial PGE2 levels 60 min after reperfusion were significantly higher in patients with good 
graft function as compared in patients with poor graft function (479 (335-748), vs. 276 (148-
579) pg/ml) (Fig. 8A). Additionally, there was a significant inverse correlation between PGE2 
levels and graft ischemia time (Fig. 8B) as well as with the time of hospital stay (Fig. 8C). 
 
DISCUSSION 
We used hCOX-2-Tg mice to investigate the role of COX-2 in the outcome of liver after IRI. 
Our data demonstrate that hCOX-2-Tg mice were significantly less susceptible to liver IRI. 
hCOX-2-Tg mice showed reduced ALT, AST and LDH levels and necrosis grade after IRI, 
which indicates a lesser liver damage when compared to Wt animals. Moreover, IPC 
attenuated IRI damage in Wt mice through the induction of endogenous COX-2 expression, 
which is mainly localized in hepatocytes. Our observation that expression of COX-2 confers 
a protective role in liver suffering IRI is supported by the fact that DFU treatment restores 
most of the IRI parameters both in Wt IPC and hCOX-2 Tg mice. These results are also 
supported by other publications, in which COX-2 expression was beneficial in rat liver IRI 
(20,33), and in the immediate human postsurgical liver transplantation period (34). 
 
Consistent with previous reports (16,27) constitutive hepatic COX-2 expression leads to 
lower plasmatic levels of pro-inflammatory cytokines (i.e. IL-1β, IL-6 and TNF-α). hCOX-2-
Tg mice presented an attenuated inflammatory response with lower levels of pro-
inflammatory markers, and higher levels of IL-10, leading to a diminished hepatic IRI. Our in 
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dependent NF-κB activation; b) an anti-apoptotic effect of COX-2, as deduced by the 
decrease of caspase-3 activation after IRI; and c) an improved antioxidant response to 
oxidative stress and decreased ROS production induced by COX-2 after IRI. 
 
Interestingly, Hamada et al. (35) reported that global COX-2 deficiency enhances Th2 
immune function and impairs neutrophil recruitment in liver IRI. Nevertheless, the same 
authors reported that selective deletion of myeloid cell derived COX-2 failed to ameliorate 
liver IRI and developed hepatic extensive necrosis and leukocyte infiltration (36). These 
authors concluded that selective myeloid COX-2 gene inactivation, which is the major source 
of COX-2 activity in non-parenchymal hepatic cells, has no effect in the progression of liver 
damage in response to IRI. However, inhibition of inducible PGE2 synthase attenuates 
reperfusion injury through inactivation of Kupffer cells and neutrophils, indicating a crucial 
role for PGs in hepatic IRI (37). In our experimental model, the results clearly support that 
constitutive expression of COX-2 in hepatic parenchymal cells lead to a diminished 
neutrophil infiltration in liver after IRI as indicated by Ly6G
+
 immunostaining and MPO 
activity.  
 
In hepatic IRI, a dead liver cell is usually present in a necrotic form but malfunctioning 
programmed cell death is also observed in the hepatic IRI process (38). We found an 
attenuated response in BAX/BCL-2 ratio and caspase 3 activity in hCOX-2-Tg mice after IRI 
in agreement with the reported anti-apoptotic effect of COX-2 activity (16,27). 
The phosphatidylinositide 3-kinase/AKT and AMPK pathways play a central role in 
integrating diverse survival signals. It is known that the AKT pathway is target of 
prostaglandins and that AKT phosphorylation is enhanced in the liver of hCOX-2-Tg 
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Tg mice after IRI may be due to a direct AKT activation through COX-2-dependent PGE2 
acting via EP2/EP4 Gβγ dimers, as reported by Rizzo et al.(40). It has been described that the 
activation of both AKT and AMPK is part of a protective mechanism to prevent IRI (41). Our 
results agree with this notion, showing not only an increase in p-AKT/AKT ratio, but also in 
the p-AMPK to AMPK ratio in hCOX-2-Tg mice after IRI. 
 
Ke et al. have reported that NRF2 has a protective role against hepatocellular damage 
induced by ischemia (42). In fact, pre-treatment with a NRF2 inducer resulted in partial 
attenuation of hepatic IRI in rats (7). It has been described that some COX-2 metabolites can 
induce a nuclear translocation of NRF2 (43) and even reduce ROS levels in a model of IRI 
(31). Our results show a clear induction of Nrf2, Hmox1, Sod1 and Sod2 expression in hCOX-
2-Tg mice after IRI when compared to Wt with a concomitant increase in the nuclear protein 
levels of NRF2 and in the activities of antioxidant enzymes, hence, leading to an induction of 
antioxidant response. This pattern was mimicked by IPC in Wt mice. 
 
Several reports have suggested that IRI is characterized by defective liver autophagy (8). In 
this work we show an impaired autophagic flux after IRI in Wt mice. The decreased 
autophagy was attenuated in hCOX-2-Tg IRI in agreement with previous works that reported 
in other cells an autophagy induction via up-regulation of COX-2 and PGE2 production (44), 
or that mPGES-2 down regulation is associated with autophagy inhibition and enhanced 
apoptosis (45). 
 
Recent experimental data suggest the involvement of endoplasmic reticulum stress (ERS) in 
several liver diseases, including IRI (46). As a proof of concept, chemical chaperones such as 
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after IRI, in Wt mice, an impaired autophagy associated with increased ERS after IRI occurs, 
involving an increase in ERS markers, such as GRP78, CHOP and phosphorylated JNK. 
Again, constitutive hepatocyte COX-2 expression attenuates ERS and activates autophagy 
after IRI. 
 
From a translational point of view, we evaluated the relationship between PGE2 levels in 
plasma and the clinical data of patients undergoing liver transplantation (LT) (48). 
Interestingly, clinical data obtained in the context of LT showed a significant association 
between arterial PGE2 levels and early graft function, evaluated by a well-known scale that 
has been employed in previous publications (49). Additionally, ischemia time was also 
inversely associated to PGE2. These results are clearly in consonance with the experimental 
results obtained in transgenic animals in which overexpression of COX-2 has protective 
effect in several experimental settings. Our results suggest that, even in the physiological 
range levels, prostaglandins may have a protective role in patients receiving liver 
transplantation.  
 
Overall, the data support beneficial and protective effects of hepatocyte COX-2 induction and 
its dependent prostaglandins during IPC as a key hepatic protective mechanism triggered 
against I/R-derived damage and might provide evidence-based support for further therapeutic 
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FIGURE LEGENDS 
Figure 1. hCOX-2-Tg mice are protected against Ischemia/Reperfusion-induced liver 
damage. 
Wt and hCOX-2-Tg mice were subjected to a warm hepatic ischemia for 90 min and to 
reperfusion (I/R) for 4 or 24 h. (A) Representative Western blot of murine COX-1 and human 
COX-2 proteins in liver extracts. (B) PGE2 levels measured by EIA in liver from hCOX-2-Tg 
vs. Wt mice. (C) Representative images of hematoxylin/eosin stained liver paraffin-embedded 
sections from Wt and hCOX-2-Tg mice after Sham or ischemia/reperfusion (I/R) at 4 h and 
24 h. Necrotic areas are marked with * and vascular congestion with ➡. (D) Plasma levels of 
ALT, AST and LDH activities from Wt and hCOX-2-Tg mice. (E) Necrosis grade assessed by 
histological examination. Scores used were 0=none, 1=mild lesion (0-20% of necrosis), 
2=moderate lesion (20-40% of necrosis), 3=severe lesion (more than 40% of necrosis). Data 
are expressed as means ± S.E. (n=5-8 per group). *P<0.05 vs. Wt-Sham; #P<0.05 vs. Wt-
I/R. 
 
Figure 2. Whole transcriptome sequencing reflects a differential gene expression profile in 
hCOX-2-Tg mice after I/R injury. 
Total RNA was obtained from Wt and hCOX-2-Tg mice after I/R at 4 h (n=4 in each 
experimental group). (A) Heat map of the two-way Hierarchical clustering (70 genes 
satisfying with fc≥2) using Z-score for normalized value (log2 based); (B) Scatter plot of 
expression level between two groups in hCOX-2 Tg mice vs Wt littermates. (C) Gene-
Enrichment test based on Gene Ontology was conducted with significant gene list. The most 
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Figure 3.  Analysis of pro-inflammatory cytokines and liver inflammation in Wt and 
hCOX-2-Tg mice after I/R injury. 
(A) Hepatic mRNA levels of pro-inflammatory markers (Il-1b, Tnfa, Il-6 Nlrp3 and Il-10) in 
sham (Sh) or ischemia/reperfusion (I/R) conditions. (B) Plasmatic levels of IL-1TNF-, 
and IL-6 were assessed by Luminex analysis. (C) MPO activity measured in liver extract and 
(D) Representative immunohistochemistry for Ly6G
+
 staining from Wt and hCOX-2-Tg mice 
after I/R. (E) Representative immunofluorescence merged images of p65 (red), albumin or 
CLEC4F (green) and DAPI (blue) from Wt and hCOX-2 Tg mice livers after I/R at 4 h. 
Specific nuclear staining is marked with . (F) Representative Western blots and 
densitometric analysis of NF-B (p65) and pIKB protein levels in nuclear and cytosolic 
extracts, respectively. Data are expressed as means ± S.E. (n=5-6 per group). *P<0.05 vs. 
Wt-Sham; #P<0.05 vs. Wt-I/R. 
Figure 4. Hepatic hCOX-2 expression leads to increased antioxidant defenses and 
decreased I/R-derived oxidative stress. 
(A) mRNA levels of Nrf2 and antioxidant genes (Hmox1, Gpx, Gsr, Sod1 and Sod2) in liver 
extracts in sham (Sh) or ischemia/reperfusion (I/R) at 4 h. (B) Analysis of NRF2 nuclear 
expression levels in liver extracts from Wt and hCOX-2-Tg mice after I/R at 4 h. (C) 
Representative merged images of NRF2 (red), albumin or CLEC4F (green) and DAPI (blue) 
immunostaining in liver from Wt and hCOX-2-Tg mice after I/R at 4 h. Specific nuclear 
staining is marked with . (D) MnSOD activity assessed by NBT reduction inhibition assay 
in native polyacrylamide gel electrophoresis. (E) Representative images of dihydroethidium 
staining in liver sections in liver from Wt and hCOX-2-Tg mice in sham (Sh) or 
ischemia/reperfusion (I/R) at 4 h. (F) Total glutathione content and Oxidized 
glutathione/Total glutathione ratio (GSSG/GSHt). Data are expressed as means ± S.E. (n=4-8 










This article is protected by copyright. All rights reserved. 
Figure 5. COX-2 expression improves autophagy and decreases ER stress markers in liver 
after I/R injury. 
(A-C) Representative Western blots and densitometric analysis of p62 (A), LC3II (B), and 
ATG7 (C) protein levels in sham (Sh) or ischemia/reperfusion (I/R) conditions. (D) 
Transmission electron microscopic micrographs of livers from Wt and hCOX-2-Tg mice after 
4 h I/R. Original magnification x4000. Autophagosomes are marked with . n means nucleus. 
(E-F) Representative Western blots and densitometric analysis of GPR78 (E), and CHOP (F) 
protein levels. Data are expressed as means ± S.E. (n=4-6 per group). *P<0.05 vs. Wt-Sham; 
#P<0.05 vs. Wt-I/R.  
 
Figure 6. Ischemic preconditioning induces Cox-2 mRNA and PGE2 production 
attenuating Ischemia/Reperfusion-induced liver damage. 
(A) Representative images of hematoxylin/eosin stained liver paraffin-embedded sections 
from Wt, Wt PC, DFU-treated Wt PC (Wt PC DFU), hCOX-2-Tg, and DFU-treated hCOX-2-
Tg mice (hCOX-2-Tg DFU) after I/R at 4 h. Necrotic areas are marked with * and vascular 
congestion with ➡. (B) Necrosis grade assessed by histological examination. Scores used 
were 0=none, 1=mild lesion (0-20% of necrosis), 2=moderate lesion (20-40% of necrosis), 
3=severe lesion (more than 40% of necrosis). (C) Plasma levels of ALT, AST and LDH 
activities. (D) PGE2 levels were measured by EIA in Wt, Wt PC, DFU-treated Wt PC, hCOX-
2-Tg, and DFU-treated hCOX-2-Tg mice after I/R at 4 h (E) Mouse (m) endogenous Cox-2 
mRNA and protein levels in Wt and Wt PC mice after I/R at 4 h. (F) Representative 
immunofluorescence merged images of mCOX-2 (red), albumin or CLEC4F (green) and 
DAPI (blue) from Wt and Wt PC mice livers after I/R at 4 h. Hepatocyte staining is marked 
with . Data are expressed as means ± S.E. (n=5-8 per group). *P<0.05 vs. Wt-Sham, 
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Figure 7. Analysis of pro-inflammatory cytokines and antioxidant genes after Ischemic 
preconditioning.  
(A) mRNA levels of pro-inflammatory markers (Il-1b, Il-6, Tnfa, Nlrp3, and Il-10) in liver 
from Wt, Wt PC, hCOX-2 and DFU-treated hCOX-2 mice in sham (Sh) or 
ischemia/reperfusion (I/R) conditions at 4 h. (B) mRNA levels of Nrf2 and its target genes 
(Hmox1, Gpx, Gsr, Sod1 and Sod2) in liver extracts from Wt, Wt PC, hCOX-2 and DFU-
treated hCOX-2 mice after I/R at 4 h. Data are expressed as means ± S.E. (n=5-8 per group). 
*P<0.05 vs. Wt-Sham; #P<0.05 vs. Wt-I/R; †P<0.05 vs. hCOX-2-Tg-I/R.  
 
Figure 8. Liver graft function respect to the level of PGE2 measured in R60 plasma. (A) 
PGE2 levels measured by EIA were analyzed in arterial plasma obtained from 63 patients 
receiving LT collected 60 min after reperfusion. Graft function was evaluated during the first 
3 days after LT; Mann-Whitney rank-sum test were used to analyzed the relationship between 
PGE2 levels and early graft dysfunction: NO, good graft function (grades I or II); YES, poor 
graft function (grades III or IV), (* P=0,026); (B-C) To assess a significant relationship 
between PGE2 levels and ischemia time (B) or length of hospital stay (C), Spearman’s 
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